Orthofix Medical, Inc. (OFIX)
12.25
+0.06
(+0.49%)
USD |
NASDAQ |
May 07, 13:40
Orthofix Medical SG&A Expense (TTM) : 421.35M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Repligen Corp. | 219.25M |
| InfuSystem Holdings, Inc. | 67.46M |
| Tandem Diabetes Care, Inc. | 444.99M |
| Abbott Laboratories | 13.01B |
| Plus Therapeutics, Inc. | 12.13M |